1. Home
  2. DNLI vs ATKR Comparison

DNLI vs ATKR Comparison

Compare DNLI & ATKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • ATKR
  • Stock Information
  • Founded
  • DNLI 2013
  • ATKR 1959
  • Country
  • DNLI United States
  • ATKR United States
  • Employees
  • DNLI N/A
  • ATKR N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • ATKR Industrial Machinery/Components
  • Sector
  • DNLI Health Care
  • ATKR Miscellaneous
  • Exchange
  • DNLI Nasdaq
  • ATKR Nasdaq
  • Market Cap
  • DNLI 2.2B
  • ATKR 2.3B
  • IPO Year
  • DNLI 2017
  • ATKR 2016
  • Fundamental
  • Price
  • DNLI $14.93
  • ATKR $68.49
  • Analyst Decision
  • DNLI Strong Buy
  • ATKR Hold
  • Analyst Count
  • DNLI 13
  • ATKR 6
  • Target Price
  • DNLI $32.64
  • ATKR $81.00
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • ATKR 399.8K
  • Earning Date
  • DNLI 11-03-2025
  • ATKR 11-20-2025
  • Dividend Yield
  • DNLI N/A
  • ATKR 1.93%
  • EPS Growth
  • DNLI N/A
  • ATKR N/A
  • EPS
  • DNLI N/A
  • ATKR 3.22
  • Revenue
  • DNLI N/A
  • ATKR $2,886,664,000.00
  • Revenue This Year
  • DNLI N/A
  • ATKR N/A
  • Revenue Next Year
  • DNLI $94,232.03
  • ATKR N/A
  • P/E Ratio
  • DNLI N/A
  • ATKR $21.26
  • Revenue Growth
  • DNLI N/A
  • ATKR N/A
  • 52 Week Low
  • DNLI $10.57
  • ATKR $49.92
  • 52 Week High
  • DNLI $33.33
  • ATKR $105.28
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.86
  • ATKR 61.00
  • Support Level
  • DNLI $15.53
  • ATKR $67.59
  • Resistance Level
  • DNLI $17.02
  • ATKR $70.43
  • Average True Range (ATR)
  • DNLI 0.79
  • ATKR 1.62
  • MACD
  • DNLI -0.19
  • ATKR 0.12
  • Stochastic Oscillator
  • DNLI 0.71
  • ATKR 65.18

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: